Back to list BIORCHESTRA Participated in Formulation and Delivery BIORCHESTRA is a leading RNA therapeutics company that develops novel RNA-based therapeutics and drug delivery systems for neurodegenerative diseases.[BBB penetration in…
Back to list BIORCHESTRA Announces 45 Million USD Series C Fundraising BIORCHESTRA is a leading RNA therapeutics company whose lead programs focus on neurodegenerative diseases using its proprietary RNA-based drug…
Back to list BIORCHESTRA, SK Biopharmaceuticals collaborate to develop miRNA-targeted therapeutics BIORCHESTRA and SK Biopharmaceuticals announced today that they have forged a partnership to research and develop new therapeutic compounds…